T3 · Product exporter position

India exports of Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) (HS 300390)

See where India stands in medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale): export scale, destination breadth, market position, growth, and reported trade history.

Explore this product View destinations

Exporter INDHS6 300390Latest year 2024Stable

Latest exports

$421.8MLatest observed lane total

Destination markets

179Reported active markets

Three-year growth

+1.1%Annualized change

Destination HHI

567Destination concentration

Weighted share

20.8%Reported market position

Exporter evidence

How strong is India in Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale)?

Reported exporter totals and calculated indicators for HS 300390. Values retain their observed coverage period.

Exporter scale

Latest exports$421.8M

Current 2024 exports$421.5M

Three-year average$438.8M

Historical peak$976.7M

Market position

Active destinations179

Destination HHI567

Weighted share20.8%

Share change+0.4 pp

Competitiveness

Three-year growth+1.1%

Volatility1.2

Maximum drawdown76.6%

TrendStable

Measure	Value	What it describes
Exporter	India	Country represented by this profile
Latest observed exports	$421.8M	Sum of latest observed destination-lane values
Current 2024 exports	$421.5M	Common-year comparison where reported
Three-year growth	+1.1%	Annualized change in exporter totals
Five-year growth	+5%	Annualized change in exporter totals
Leading destination	USA	Destination with the largest observed export value
Leading destination share	13.2%	Share of observed exporter totals
Destination concentration	567	HHI across destination markets
Weighted share change	+0.4 pp	Value-weighted latest change in market share
Limited-history lanes	5.1%	Share of lanes with shorter history

Destination markets

Where does India sell medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale)?

Leading destination observations ranked by reported export value, with market position and access context.

Destination	Latest exports	Market share	Growth	Access	Signal
USA, Puerto Rico and US Virgin Islands	$55.8M	3.1%	+1%	0% tariff	Growing
Brazil	$41.8M	39.2%	-1.1%	0.3% tariff	Accelerating
Belgium	$41.5M	7.4%	+58.8%	0% tariff	Accelerating
Hungary	$33.5M	24%	+1,259.6%	0.1% tariff	Accelerating
Germany	$24.7M	1.3%	-3.4%	0% tariff	Accelerating
Mexico	$23.2M	26.1%	-8.1%	0.1% tariff	Growing

Destination

USA, Puerto Rico and US Virgin Islands

Latest exports: $55.8M
Market share: 3.1%
Growth: +1%
Access: 0% tariff
Signal: Growing

Destination

Brazil

Latest exports: $41.8M
Market share: 39.2%
Growth: -1.1%
Access: 0.3% tariff
Signal: Accelerating

Destination

Belgium

Latest exports: $41.5M
Market share: 7.4%
Growth: +58.8%
Access: 0% tariff
Signal: Accelerating

Destination

Hungary

Latest exports: $33.5M
Market share: 24%
Growth: +1,259.6%
Access: 0.1% tariff
Signal: Accelerating

Destination

Germany

Latest exports: $24.7M
Market share: 1.3%
Growth: -3.4%
Access: 0% tariff
Signal: Accelerating

Destination

Mexico

Latest exports: $23.2M
Market share: 26.1%
Growth: -8.1%
Access: 0.1% tariff
Signal: Growing

Price intelligence

How does India's price position vary?

Price comparisons are shown where market-level unit-value observations are available. They describe reported trade values and quantities, not quoted selling prices.

Highest reported price

Croatia: $3.9M / ton.

Lowest reported price

Bahamas: $737.8 / ton.

Median price

$26.6K / ton across reported markets.

Export trend

Reported export history

Annual observations for India and HS 300390 where available.

Year	Exports	Year-on-year change	Active destinations
2010	$310.0M	+29.3%	176
2011	$382.2M	+23.3%	179
2012	$412.4M	+7.9%	172
2013	$397.5M	-3.6%	176
2014	$331.3M	-16.7%	175
2015	$392.1M	+18.3%	173
2016	$359.0M	-8.4%	178
2017	$321.9M	-10.3%	171
2018	$339.7M	+5.5%	173
2019	$330.6M	-2.7%	172
2020	$335.9M	+1.6%	177
2021	$408.4M	+21.6%	174
2022	$444.2M	+8.8%	175
2023	$450.6M	+1.4%	180
2024	$421.5M	-6.5%	179

Exporter context

India economy and trade network

The exporter profile adds country-level trade and structural context to the selected product position. These indicators describe the country overall and are not limited to HS 300390.

India has reported exports of $434.2B and a trade balance of -$221.5B in 2024.

Available structural indicators include 24.9% trade openness, 35.7% investment, and 270 active trade partners.

Reported values

Export totals and destination values describe reported merchandise trade for the stated exporter, HS6 classification, and available year.

Calculated indicators

Growth, concentration, weighted share, volatility, drawdown, and price comparisons are calculated from reported observations.

Coverage

Missing values remain “Not reported”. Country-level indicators are presented separately from product-level observations.

Frequently asked questions

Questions about India medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) exports

Quick answers based on the figures and coverage shown on this page.

How strong is this exporter?

Use latest exports, destination breadth, growth, concentration, and weighted share together rather than relying on one measure.

Which markets are most important?

The destination table ranks reported markets by the latest observed export value.

Does the price section show quotes?

No. It summarizes reported trade value and quantity observations converted to unit values.

What should be checked next?

Compare this exporter with buyer markets, corridors, and the product overview before making a commercial decision.